A newly NHS-approved weight loss drug, Mounjaro, is being blamed for the tragic death of a 58-year-old Scottish nurse after ...

Tensions had been mounting in the Dutch capital over Israel’s campaigns in Gaza and Lebanon, even before the Europa League ...

Denmark-based Novo Nordisk teased some new details about a potential Ozempic successor during a call with investors on Tuesday. Sales of the company’s current blockbuster weight loss drug, Wegovy, ...

Danish pharmaceutical giant Novo Nordisk sees a significant increase in profits and sales despite production constraints.

3️⃣ Poignant postcard: In 1912, a first-class passenger on the Titanic scrawled a message in pencil to someone back home in ...

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted Wednesday strong third-quarter earnings despite being held back by ...

The FTSE 100 was 0.07% lower at 8,166, Germany's DAX down 1.14% at 19,036, France's CAC 0.51% lower at 7,369 and Italy's FTSE ...

Novo Nordisk reported forecast-beating quarterly sales of its popular Wegovy weight-loss drug on Wednesday, sending its shares up nearly 9%.

Novo Nordisk added 7.4% after the weight-loss and diabetes drugmaker reported better-than-expected quarterly sales of its ...

TODAY'S TOP HEADLINES Novo Nordisk's Blockbuster Wegovy Drug Sales Beat Expectations Novo Nordisk's blockbuster Wegovy weight-loss drug beat sales expectations in the third quarter, sending shares ...

While this move from Sanofi is not completely unprecedented, it did not go unnoticed and received considerable coverage, ...